GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (FRA:LDBB) » Definitions » Market Cap

H. Lundbeck AS (FRA:LDBB) Market Cap : €4,764 Mil (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). H. Lundbeck AS's share price for the quarter that ended in Mar. 2024 was €3.798. H. Lundbeck AS's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 992 Mil. Therefore, H. Lundbeck AS's market cap for the quarter that ended in Mar. 2024 was €3,768 Mil.

H. Lundbeck AS's quarterly market cap declined from Sep. 2023 (€4,412 Mil) to Dec. 2023 (€3,805 Mil) and declined from Dec. 2023 (€3,805 Mil) to Mar. 2024 (€3,768 Mil).

H. Lundbeck AS's annual market cap increased from Dec. 2021 (€0 Mil) to Dec. 2022 (€3,161 Mil) and increased from Dec. 2022 (€3,161 Mil) to Dec. 2023 (€3,805 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. H. Lundbeck AS's Enterprise Value for Today is €4,637 Mil.


H. Lundbeck AS Market Cap Historical Data

The historical data trend for H. Lundbeck AS's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H. Lundbeck AS Market Cap Chart

H. Lundbeck AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 3,161.20 3,805.35

H. Lundbeck AS Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,862.15 4,015.04 4,412.46 3,805.35 3,767.66

Competitive Comparison of H. Lundbeck AS's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, H. Lundbeck AS's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


H. Lundbeck AS's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, H. Lundbeck AS's Market Cap distribution charts can be found below:

* The bar in red indicates where H. Lundbeck AS's Market Cap falls into.



H. Lundbeck AS Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

H. Lundbeck AS's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€3.836*992.011
=€3,805

H. Lundbeck AS's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=€3.798*992.011
=€3,768

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


H. Lundbeck AS  (FRA:LDBB) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


H. Lundbeck AS Market Cap Related Terms

Thank you for viewing the detailed overview of H. Lundbeck AS's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


H. Lundbeck AS (FRA:LDBB) Business Description

Address
Ottiliavej 9, Valby, DNK, 2500
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system, or CNS, drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.

H. Lundbeck AS (FRA:LDBB) Headlines

No Headlines